Risk-stratified care management is a cornerstone of patient-centered medical home models, but studies on patients’ perspectives of it are scarce. We explored patients’ experiences with care management, what they found useful, and what needs improvement.
Antibiotic prescribing has become viewed as a patient safety and quality-of-care issue. The authors analyzed quality measures related to appropriate antibiotic prescribing and testing.
Development, validation, and application of hepatitis C case-finding algorithms to describe the care cascade among a commercially insured population in the United States.
Patients with low back pain have a high opioid burden, which increases following spinal fusion surgery; 27% of fusion patients filled opioid prescriptions at least 12 months post surgery.
Targeted messaging that encourages heavy ED users in managed care to contact their primary care providers before ED visits shows promise.
A slight decrease in the convenience of ordering a laboratory test led to a dramatic decrease in test utilization.
Although we found no DCIS treatment disparities by race/ethnicity, use of adjuvant radiation therapy was less among older women and among residents of poorer neighborhoods.
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Findings suggest that some at-risk patients may not be receptive to in-home transition interventions and that opting out may be associated with higher odds of hospital readmission.
This study explores self-reported reasons for primary nonadherence among patients newly prescribed statin medication in an integrated health delivery system.
Initial experience with the Diabetes Prevention and Control Alliance indicates that large-scale prevention and disease control management programs make economic sense.
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
Worldwide, more than half a million new cases of hepatocellular carcinoma (HCC) are diagnosed annually. The incidence of HCC in the United States is rising with an estimated 31,000 new cases in 2018. Disease prognosis remains poor, with a 5-year survival rate across all disease stages estimated between 10%-20%, and 3% for those diagnosed with distant disease. Although morbidity is significant, especially among patients with advanced-stage disease, limited information exists on the humanistic and economic burden of HCC.
This editorial discusses the cost implication of bariatric surgery and whether or not return on investment analysis should be used to make coverage decisions.
Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.
Value-based programs such as accountable care organizations appear to encourage the adoption and spread of care coordination activities by hospitals.
An examination of socioeconomic disparities in cervical cancer screening across ethnic groups in the United States using concentration indices and probit regression analyses.
This study analyzes the current coverage designs for hepatitis C virus drugs by Medicare Part D plans.